A series of factors contributed to this growth, including increasing income levels, an aging population and improvements in the medical reimbursement ratio. Despite this growth, the orthopedic device industry in China lags behind other countries. For instance, China’s leading orthopedic devices companies Trauson, China Kanghui and Weigao Group held a market share of just 4.6 percent, 3.9 percent and 2.9 percent, respectively, in 2011.
More Articles on Orthopedic Devices:
Cleveland Clinic Receives $2.8M for Orthopedic Initiatives
Study: Regulations, Taxes Pose New Challenges for US Medical Device Industry
Moving Forward With Cartilage Regeneration: Q&A With Regentis CEO Dr. Alastair Clemow
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.